Objective: To verify the feasibility, tolerability and efficacy of the combination of captopril (75 mg/day) and candesartan (8 mg/day) in early postinfarction phases of not thrombolysed and ...

Blood pressure was controlled continuously for 6 hours after candesartan administration; group B (36 patients) received captopril (75 mg/day) and placebo. Laboratory measurements, including ...